Targeting of cytotoxic cells with heterocrosslinked antibodies.
Segal
D M
DM
Immunology Branch, National Cancer Institute, Bethesda, Maryland.
Wunderlich
J R
JR
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*